Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Wolfe Research Inaugural Healthcare Conference Transcript

Nov 06, 2019 / 08:10PM GMT
Release Date Price: $56.96 (+1.01%)
Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

All right. We're going to go ahead and begin. You want to make sure that microphone -- we'll see. Maybe it's fine. Sometimes (inaudible) in this room. So happy to be here with Bristol-Myers. Well, I'm Tim Anderson, the pharma analyst at Wolfe. We have Giovanni Caforio, who's the CEO and Chairman of the Board. He's been with the company since 2000 and prior to that his 12 years at Abbott Labs. He's also the current Chairman of the PhRMA Board of Directors, so PhRMA being the trade organization. And you've been in that position for maybe a year?

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Since September 1. So less than a year.

Questions & Answers

Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

Okay. So I thought we'd start off with some general questions. And a lot of these initial questions are going to be on the transaction that's pending with Celgene, as you might imagine. So let

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot